About
Ascentage Pharma Grp International (HK:6855) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 5 2026
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
Jan 15 2026
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Jan 7 2026
Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288
Financials
Revenue
HK$574.12 M
Market Cap
HK$19.43 B
EPS
-3.55
Translate